Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2020 Filed Sep 2, 2020 20:33 UTC |
Santiago Karen MurphySVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 642 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000238 · wf-form4_159907876937346.xml · nonDerivative · entry 1 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of restricted stock units granted on September 1, 2016. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:33 UTC |
Price Paula ADirector
|
GrantDeferred Share Units · Derivative | 1,306.279 | $60.97 | $79,643.83 |
DisclosureSEC source: 0000014272-20-000240 · wf-form4_159907880683474.xml · derivative · entry 1 Price Paula A · CIK 0001369240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,306.279 Underlying: Common Stock, $0.10 par value · 1,306.279 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · shares: Represents pro rata portion of the 2020 annual Deferred Share Unit awards granted to the Company's directors. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 20:34 UTC |
Caforio GiovanniDirector · Chairman and CEO
|
SaleCommon Stock, $0.10 par value | 39,840 | $62.70 | $2,497,968.00 |
DisclosureSEC source: 0000014272-20-000241 · wf-form4_159907884066675.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,584.333 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.68 to $62.75, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 22:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
SaleCommon Stock, $0.10 par value | 5,327 | $64.00 | $340,928.00 |
DisclosureSEC source: 0000014272-20-000233 · wf-form4_159787532506693.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 20:55 UTC |
LEUNG SANDRAEVP, General Counsel
|
SaleCommon Stock, $0.10 par value | 141,420 | $63.24 | $8,943,400.80 |
DisclosureSEC source: 0000014272-20-000231 · wf-form4_159769769257253.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,744.333 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.92 to $63.58, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:43 UTC |
Elkins David VEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 46,402 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · derivative · entry 4 Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,403 Underlying: Common Stock, $0.10 par value · 46,402 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019. F1 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:43 UTC |
Elkins David VEVP, Chief Financial Officer
|
Tax withholdingCommon Stock, $0.10 par value | 25,916 | $58.66 | $1,520,232.56 |
DisclosureSEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · nonDerivative · entry 2 Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,782 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 20:43 UTC |
Elkins David VEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.10 par value | 46,402 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000225 · wf-form4_159657365724597.xml · nonDerivative · entry 1 Elkins David V · CIK 0001451604 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in three equal annual installments beginning on August 1, 2019. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:54 UTC |
Santiago Karen MurphySVP & Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · derivative · entry 3 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,208 Underlying: Common Stock, $0.10 par value · 1,069 shares Expires 2023-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. F1 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:54 UTC |
Santiago Karen MurphySVP & Controller
|
Tax withholdingCommon Stock, $0.10 par value | 367 | $59.43 | $21,810.81 |
DisclosureSEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · nonDerivative · entry 2 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,748 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:54 UTC |
Santiago Karen MurphySVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000210 · wf-form4_159372325985864.xml · nonDerivative · entry 1 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:56 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionRestricted Stock Units · Derivative | 9,356 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · derivative · entry 3 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,069 Underlying: Common Stock, $0.10 par value · 9,356 shares Expires 2023-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. F1 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:56 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 4,463 | $59.43 | $265,236.09 |
DisclosureSEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · nonDerivative · entry 2 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,893 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:56 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 9,356 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000211 · wf-form4_159372332690183.xml · nonDerivative · entry 1 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units vest in four equal annual installments beginning on July 1, 2020. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:57 UTC |
Emmens MatthewDirector
|
GrantDeferred Share Units · Derivative | 616.497 | $58.80 | $36,250.02 |
DisclosureSEC source: 0000014272-20-000212 · wf-form4_159372340624194.xml · derivative · entry 1 Emmens Matthew · CIK 0001298332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,667.561 Underlying: Common Stock, $0.10 par value · 616.497 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:58 UTC |
BONNEY MICHAEL WDirector
|
GrantDeferred Share Units · Derivative | 392.432 | $58.80 | $23,075.00 |
DisclosureSEC source: 0000014272-20-000213 · wf-form4_159372347744271.xml · derivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,639.199 Underlying: Common Stock, $0.10 par value · 392.432 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:00 UTC |
BERTOLINI ROBERT JDirector
|
GrantDeferred Share Units · Derivative | 595.238 | $58.80 | $34,999.99 |
DisclosureSEC source: 0000014272-20-000214 · wf-form4_159372355114736.xml · derivative · entry 1 BERTOLINI ROBERT J · CIK 0001270263 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,384.859 Underlying: Common Stock, $0.10 par value · 595.238 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:02 UTC |
Arduini Peter JDirector
|
GrantDeferred Share Units · Derivative | 616.497 | $58.80 | $36,250.02 |
DisclosureSEC source: 0000014272-20-000215 · wf-form4_159372365790382.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,664.192 Underlying: Common Stock, $0.10 par value · 616.497 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:05 UTC |
Paliwal Dinesh CDirector
|
GrantDeferred Share Units · Derivative | 659.014 | $58.50 | $38,552.32 |
DisclosureSEC source: 0000014272-20-000216 · wf-form4_159372387823604.xml · derivative · entry 1 Paliwal Dinesh C · CIK 0001360224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,743.632 Underlying: Common Stock, $0.10 par value · 659.014 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:05 UTC |
LACY ALAN JDirector
|
GrantDeferred Share Units · Derivative | 212.585 | $58.80 | $12,500.00 |
DisclosureSEC source: 0000014272-20-000217 · wf-form4_159372391667741.xml · derivative · entry 1 LACY ALAN J · CIK 0001200232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,952.187 Underlying: Common Stock, $0.10 par value · 212.585 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:07 UTC |
Haller Julia ADirector
|
GrantDeferred Share Units · Derivative | 528.893 | $58.80 | $31,098.91 |
DisclosureSEC source: 0000014272-20-000218 · wf-form4_159372397567975.xml · derivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,930.548 Underlying: Common Stock, $0.10 par value · 528.893 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:08 UTC |
GROBSTEIN MICHAELDirector
|
GrantDeferred Share Units · Derivative | 114.469 | $58.80 | $6,730.78 |
DisclosureSEC source: 0000014272-20-000219 · wf-form4_159372408446045.xml · derivative · entry 1 GROBSTEIN MICHAEL · CIK 0001222342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,898.191 Underlying: Common Stock, $0.10 par value · 114.469 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:11 UTC |
YALE PHYLLIS RDirector
|
GrantDeferred Share Units · Derivative | 488.946 | $58.80 | $28,750.02 |
DisclosureSEC source: 0000014272-20-000220 · wf-form4_159372425107000.xml · derivative · entry 1 YALE PHYLLIS R · CIK 0001269070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,890.601 Underlying: Common Stock, $0.10 par value · 488.946 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:14 UTC |
Storch Gerald LDirector
|
GrantDeferred Share Units · Derivative | 579.353 | $58.80 | $34,065.96 |
DisclosureSEC source: 0000014272-20-000222 · wf-form4_159372439003181.xml · derivative · entry 1 Storch Gerald L · CIK 0001205004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,606.059 Underlying: Common Stock, $0.10 par value · 579.353 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:13 UTC |
Vousden Karen HDirector
|
GrantDeferred Share Units · Derivative | 164.753 | $58.80 | $9,687.48 |
DisclosureSEC source: 0000014272-20-000221 · wf-form4_159372432639233.xml · derivative · entry 1 Vousden Karen H · CIK 0001723884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,077.3 Underlying: Common Stock, $0.10 par value · 164.753 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:15 UTC |
Samuels Theodore R. IIDirector
|
GrantDeferred Share Units · Derivative | 552.721 | $58.80 | $32,499.99 |
DisclosureSEC source: 0000014272-20-000223 · wf-form4_159372446637977.xml · derivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,049.36 Underlying: Common Stock, $0.10 par value · 552.721 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:15 UTC |
Paliwal Dinesh CDirector
|
PurchaseCommon Stock, $0.10 par value | 9,174 | $54.50 | $499,983.00 |
DisclosureSEC source: 0000014272-20-000193 · wf-form4_159234210804505.xml · nonDerivative · entry 1 Paliwal Dinesh C · CIK 0001360224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,109.35 Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:15 UTC |
Haller Julia ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · derivative · entry 4 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 558 shares Expires 2020-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · shares: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F3 · derivative.exercise_date: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F3 · derivative.expiration_date: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:15 UTC |
Haller Julia ADirector
|
Exercise / conversionCommon Stock, $0.10 par value | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · nonDerivative · entry 2 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: One June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:16 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · derivative · entry 5 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 558 shares Expires 2020-06-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · shares: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F3 · derivative.exercise_date: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F3 · derivative.expiration_date: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. Read SEC document |
| June 14, 2020 Filed Jun 16, 2020 21:16 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · nonDerivative · entry 2 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 14, 2017, the reporting person was granted 1,674 restricted stock units, vesting in three equal installments beginning on June 14, 2018. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 13, 2020 Filed Jun 16, 2020 21:15 UTC |
Haller Julia ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · derivative · entry 3 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902 Underlying: Common Stock, $0.10 par value · 903 shares Expires 2021-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F1 · derivative.exercise_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F1 · derivative.expiration_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. Read SEC document |
| June 13, 2020 Filed Jun 16, 2020 21:15 UTC |
Haller Julia ADirector
|
Exercise / conversionCommon Stock, $0.10 par value | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000194 · wf-form4_159234213031831.xml · nonDerivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 13, 2020 Filed Jun 16, 2020 21:16 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · derivative · entry 4 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902 Underlying: Common Stock, $0.10 par value · 903 shares Expires 2021-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F1 · derivative.exercise_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F1 · derivative.expiration_date: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. Read SEC document |
| June 13, 2020 Filed Jun 16, 2020 21:16 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000195 · wf-form4_159234215241704.xml · nonDerivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 13, 2018, the reporting person was granted 2,708 restricted stock units, vesting in three equal installments beginning on June 13, 2019. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:39 UTC |
Haller Julia ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000176 · wf-form4_159138957133577.xml · derivative · entry 2 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 Underlying: Common Stock, $0.10 par value · 2,949 shares Expires 2022-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:39 UTC |
Haller Julia ADirector
|
Exercise / conversionCommon Stock, $0.10 par value | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000176 · wf-form4_159138957133577.xml · nonDerivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:40 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000177 · wf-form4_159138960535420.xml · derivative · entry 3 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,898 Underlying: Common Stock, $0.10 par value · 2,949 shares Expires 2022-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:40 UTC |
BONNEY MICHAEL WDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000177 · wf-form4_159138960535420.xml · nonDerivative · entry 1 BONNEY MICHAEL W · CIK 0001219016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 3, 2019, the reporting person was granted 8,847 restricted stock units, vesting in three equal installments beginning on June 3, 2020. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Exercise / conversionRestricted Stock Units · Derivative | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · derivative · entry 3 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,463 Underlying: Common Stock, $0.10 par value · 2,154 shares Expires 2023-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F4 · date: Due to an administrative error, this Form 4 was not timely filed. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.exercise_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F1 · derivative.expiration_date: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Tax withholdingCommon Stock, $0.10 par value | 738 | $60.21 | $44,434.98 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 2 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,861 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 23:15 UTC |
Eid JosephSVP,Head Glob. Medical Affairs
|
Exercise / conversionCommon Stock, $0.10 par value | 2,154 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000181 · wf-form4_159174451571136.xml · nonDerivative · entry 1 Eid Joseph · CIK 0001780247 · SVP,Head Glob. Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 3, 2019, the reporting person was granted 8,617 restricted stock units, vesting in four equal installments beginning on June 3, 2020. F2 · price: Each restricted stock unit converts into one share of common stock upon vesting. Read SEC document |
| May 22, 2020 Filed May 26, 2020 21:17 UTC |
Dubow AdamSVP,ChiefCompliance&EthicsOff.
|
SaleCommon Stock, $0.10 par value | 3,200 | $61.01 | $195,232.00 |
DisclosureSEC source: 0000014272-20-000173 · wf-form4_159052780720866.xml · nonDerivative · entry 1 Dubow Adam · CIK 0001744507 · SVP,ChiefCompliance&EthicsOff. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,086.152 Read SEC document |
| May 19, 2020 Filed May 21, 2020 21:22 UTC |
Schmukler Louis SEVP,Pres.,Glob.Prod. & Supply
|
SaleCommon Stock, $0.10 par value | 25,000 | $62.68 | $1,567,000.00 |
DisclosureSEC source: 0000014272-20-000171 · wf-form4_159009615262854.xml · nonDerivative · entry 1 Schmukler Louis S · CIK 0001530894 · EVP,Pres.,Glob.Prod. & Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,777.466 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $62.66 to $62.72, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionRestricted Stock Units · Derivative | 2,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · derivative · entry 4 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,908 shares Expires 2020-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018. F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on May 1, 2018. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
AHMED NADIMEVP and President, Hematology
|
Tax withholdingCommon Stock, $0.10 par value | 1,433 | $60.26 | $86,352.58 |
DisclosureSEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · nonDerivative · entry 2 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,030 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
AHMED NADIMEVP and President, Hematology
|
Exercise / conversionCommon Stock, $0.10 par value | 2,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000162 · wf-form4_158871174702049.xml · nonDerivative · entry 1 AHMED NADIM · CIK 0001731193 · EVP and President, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionRestricted Stock Units · Derivative | 10,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · derivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 10,707 shares Expires 2020-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018. F1 · derivative.exercise_date: The restricted stock unit vests in three equal installments beginning on May 1, 2018. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 5,274 | $60.26 | $317,811.24 |
DisclosureSEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,776 F2 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 10,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-20-000163 · wf-form4_158871176971185.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock unit vests in three equal installments beginning on May 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.